ARTICLE | Clinical News
Celebrex celecoxib: Phase IV data; Marketed
January 16, 2001 8:00 AM UTC
Researchers at Vanderbilt University reported in The New England Journal of Medicine results of a study of celecoxib in 27 patients with stable chronic asthma who experienced a 20 percent decrease in ...